XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.3Close
Condensed Consolidated Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
Premiums $ 72,339 $ 64,491 $ 217,599 $ 192,457
Investment and other income 997 513 2,910 1,175
Total revenues 92,361 80,894 277,195 241,375 Close
Operating costs:        
Medical costs 59,550 52,635 179,663 157,251
Operating costs 13,855 11,663 41,289 34,773
Cost of products sold 9,423 8,306 28,576 25,389
Depreciation and amortization 1,007 828 2,998 2,418
Total operating costs 83,835 73,432 252,526 219,831
Earnings from operations 8,526 7,462 24,669 21,544
Interest expense (834) (516) (2,416) (1,416) Close
Earnings before income taxes 7,692 6,946 22,253 20,128 Close
Provision for income taxes (1,654) (1,562) (4,784) (4,397) Close
Net earnings 6,038 5,384 17,469 15,731 Close
Earnings attributable to noncontrolling interests (197) (122) (543) (372)
Net earnings attributable to UnitedHealth Group common shareholders $ 5,841 $ 5,262 $ 16,926 $ 15,359
Earnings per share attributable to UnitedHealth Group common shareholders:        
Basic $ 6.31 $ 5.63 $ 18.20 $ 16.37
Diluted $ 6.24 $ 5.55 $ 18.01 $ 16.15
Basic weighted-average number of common shares outstanding 926 935 930 938
Dilutive effect of common share equivalents 10 13 10 13
Diluted weighted-average number of common shares outstanding 936 948 940 951
Anti-dilutive shares excluded from the calculation of dilutive effect of common share equivalents 6 3 6 3
Products        
Revenues:        
Revenue from Products and Services $ 10,354 $ 9,190 $ 31,272 $ 28,026
Services        
Revenues:        
Revenue from Products and Services $ 8,671 $ 6,700 $ 25,414 $ 19,717